연구개발

전문가와 협업을 통해 다양한 R&D에 투자 함으로써 언제나 더 나은 미래를 모색 합니다.

Pipeline

개발현황

  • Formulation (20)
  • Pre-Clinical (6)
  • Phase 1(7)
  • Phase 2(1)
  • Phase 3(5)
  • NDA (1)
    • UI054
    • UI009, UI010
    • UI017
    • UI020
    • UI015
    • UI050
    • UI049
    • UI046
    • UI051
    • UI038, UI039,UI040
    • UI047
    • UI053
    • UI055
    • UI056
    • UI057
    • UI027
    • UI048
    • UI036
    • UI032
    • UI030, UI031
    • UI033, UI034
    • UI035
    • UI014
    • UI018
    • UI028
    • UI022, UI023
    • UI037
    • UI026
    • UI026
    • UI018
    • UI028
    • UI022, UI023
    • UI044
  • Controlled Release (2)
  • FDC (12)
  • BA Improvement (5)
  • DPI (6)
  • New Salt/Co-crystal (9)
  • New Formulation (3)

발매일정

  • 2018

    • 스토바코R정 0.5,1(Smoking Cessation agent)

      New Salt

  • 2019

    • UI026(Antitussive)

      New dosage form

    • UI014(Lipid modifying agent)

      New dosage form

    • UI035(Nootropics & Neurotonics)

      New dosage form

    • UI044, UI054 (Lipid modifying agent)

      New dosage form

  • 2020

    • UI018(Lipid modifying agent)

      New Combination

    • UI020(Antidiabetics)

      New dosage form

    • UI017(Platelet aggregation inh.)

      New dosage form

    • UI009, UI010(COPD)

      DPI

  • 2021

    • UI055(Rheumatoid Arthritis)

      New Salt

    • UI036(Platelet aggregation inh.)

      New dosage form

    • UI015(NSAIDs)

      New dosage form

    • UI028(Functional GI disorder)

      New Combination

    • UI022, UI023(Platelet aggregation inh.)

      New Combination

    • UI050(Antidiabetics)

      Co-crystal

  • 2022

    • UI032(NSAIDs)

      New Combination

    • UI046(Nootropics & Neurotonics)

      Controlled Release

    • UI037, UI051(Antidiabetics)

      New Salt

    • UI038, UI039, UI040(Antidiabetics)

      New Combination

    • UI047(Antidiabetics)

      New Combination

    • UI030, UI031(COPD)

      New Device, Isomer

  • 2023

    • UI053 (Chronic Pain)

      New Combination

    • UI049(NERD)

      New Combination

  • 2024

    • UI056(Rheumatoid Arthritis)

      Controlled Release

    • UI057(Overactive Bladder)

      Controlled Release

  • 2025

    • UI033, UI034(Asthma)

      Isomer

    • UI048(Antidiabetics, Pain)

      New Combination

    • UI027(Antitussive)

      New Combination

개인정보처리방침

개인정보처리방침